Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy. - Johns C; Erickson C; Jacobs A; Moon J; Baggott C; Dagher R; Nadel H; Balagtas J; Aftandilian C; Ramakrishna S; Lacayo N; Davis KL; et al. (Frontiers in immunology, 2024)